| Year |
Citation |
Score |
| 2023 |
Belga S, Hussain S, Avery RK, Nauroz Z, Durand CM, King EA, Massie A, Segev DL, Connor AE, Bush EL, Levy RD, Shah P, Werbel WA. Impact of recipient age on mortality among CMV-seronegative lung transplant recipients with CMV-seropositive donors. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. PMID 38061469 DOI: 10.1016/j.healun.2023.11.017 |
0.322 |
|
| 2023 |
Barreras H, Copsel SN, Bader CS, Ding Y, Wolf D, Cash C, Stacey CJ, Benjamin C, Seavey MM, Wolf J, Jasuja RR, Pfeiffer B, Hill GR, Komanduri KV, Jurecic R, ... ... Levy RB, et al. Treg amelioration of GVHD following allo/xeno-HSCT using mobilized mouse and human peripheral blood donors. Transplantation and Cellular Therapy. PMID 36804930 DOI: 10.1016/j.jtct.2023.02.015 |
0.306 |
|
| 2022 |
Copsel SN, Wolf D, Pfeiffer B, Barreras H, Perez VL, Levy RB. Recipient Tregs: Can They Be Exploited for Successful Hematopoietic Stem Cell Transplant Outcomes? Frontiers in Immunology. 13: 932527. PMID 35799783 DOI: 10.3389/fimmu.2022.932527 |
0.54 |
|
| 2022 |
Wolf D, Barreras H, Copsel SN, Komanduri KV, Levy RB. Improved NK cell recovery following the use of PTCy or Treg expanded donors in experimental MHC-matched allogeneic BMT. Transplantation and Cellular Therapy. PMID 35302008 DOI: 10.1016/j.jtct.2022.03.012 |
0.536 |
|
| 2021 |
Levy RB, Mousa HM, Lightbourn CO, Shiuey EJ, Latoni D, Duffort S, Flynn R, Du J, Barreras H, Zaiken M, Paz K, Blazar BR, Perez VL. Analyses and Correlation of Pathologic and Ocular Cutaneous Changes in Murine Graft versus Host Disease. International Journal of Molecular Sciences. 23. PMID 35008621 DOI: 10.3390/ijms23010184 |
0.351 |
|
| 2021 |
Stehlik J, Christie JD, Goldstein DR, Amarelli C, Bertolotti A, Chambers DC, Dorent R, Gonzalez-Vilchez F, Parameshwar J, Perch M, Zuckermann A, Coll E, Levy RD, Atik FA, Gomez-Mesa JE, et al. The evolution of the ISHLT transplant registry. Preparing for the future. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. PMID 34657795 DOI: 10.1016/j.healun.2021.09.007 |
0.392 |
|
| 2021 |
Soifer M, Mousa HM, Levy RB, Perez VL. Understanding Immune Responses to Surgical Transplant Procedures in Stevens Johnsons Syndrome Patients. Frontiers in Medicine. 8: 656998. PMID 34095169 DOI: 10.3389/fmed.2021.656998 |
0.367 |
|
| 2021 |
Lightbourn CO, Wolf D, Copsel SN, Wang Y, Pfeiffer BJ, Barreras H, Bader CS, Komanduri KV, Perez VL, Levy RB. Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection. Frontiers in Immunology. 12: 636789. PMID 33737937 DOI: 10.3389/fimmu.2021.636789 |
0.554 |
|
| 2021 |
Bader CS, Jin L, Levy RB. STING and Transplantation: Can targeting this pathway improve outcomes? Blood. PMID 33619537 DOI: 10.1182/blood.2020008911 |
0.488 |
|
| 2020 |
Bader CS, Barreras H, Lightbourn CO, Copsel SN, Wolf D, Meng J, Ahn J, Komanduri KV, Blazar BR, Jin L, Barber GN, Roy S, Levy RB. STING differentially regulates experimental GVHD mediated by CD8 versus CD4 T cell subsets. Science Translational Medicine. 12. PMID 32669421 DOI: 10.1126/Scitranslmed.Aay5006 |
0.615 |
|
| 2020 |
Lightbourn CO, Copsel SN, Bader CS, Wolf D, Barreras H, Levy RB. TNFRSF25 and CD25 Stimulation Expands Tregs and ILC2s in the GI Tract: Recipient Modulation Pre-HSCT Biology of Blood and Marrow Transplantation. 26: S54. DOI: 10.1016/j.bbmt.2019.12.128 |
0.343 |
|
| 2020 |
Bader CS, Barreras H, Lightbourn CO, Copsel SN, Wolf D, Meng J, Ahn J, Komanduri KV, Blazar BR, Jin L, Barber GN, Roy S, Levy RB. The Innate Immune Sensor Sting Promotes Donor CD8+ T Cell Activation and Recipient APC Death Early after Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 26: S29. DOI: 10.1016/j.bbmt.2019.12.099 |
0.562 |
|
| 2019 |
Müller AM, Min D, Wernig G, Levy RB, Perez VL, Herretes S, Florek M, Burnett C, Weinberg K, Shizuru JA. Modeling chronic Graft-vs-Host disease in MHC-matched mouse strains: genetics, graft composition and tissue targets. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31415899 DOI: 10.1016/J.Bbmt.2019.08.001 |
0.587 |
|
| 2019 |
Copsel S, Wolf D, Komanduri KV, Levy RB. The promise of CD4+FoxP3+ regulatory T cell manipulation in vivo: applications for allogeneic hematopoietic stem cell transplantation. Haematologica. PMID 31221786 DOI: 10.3324/haematol.2018.198838 |
0.515 |
|
| 2019 |
Lightbourn CO, Lozano C, Bader CS, Copsel SN, Wolf D, Barreras H, Levy RB. The Location of CD4+FoxP3+ Cells with Regard to CD25 and TNFRSF25 Receptor Signals Matters: Different Requirements for GI and Peripheral Tregs Blood. 134: 1920-1920. DOI: 10.1182/blood-2019-131076 |
0.336 |
|
| 2019 |
Bader CS, Barreras H, Lightbourn CO, Copsel SN, Wolf D, Meng J, Ahn J, Komanduri KV, Blazar BR, Jin L, Barber GN, Roy S, Levy RB. The Innate Immune Sensor Sting Promotes Donor CD8+ T Cell Activation and Recipient APC Death Early after Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Blood. 134: 3202-3202. DOI: 10.1016/J.Bbmt.2019.12.099 |
0.637 |
|
| 2019 |
Nahas G, Barreras H, Bader CS, Copsel S, Wolf D, Kale B, Levy RB, Komanduri KV. Sequential Cyclophosphamide and Trametinib Improve Clinical Graft Versus Host Disease and Survival in Murine Hematopoietic Stem Cell Transplant Biology of Blood and Marrow Transplantation. 25: S296-S297. DOI: 10.1016/j.bbmt.2018.12.675 |
0.449 |
|
| 2019 |
Barreras H, Bader CS, Copsel S, Kale B, Pfeiffer BJ, Lozano C, Lightbourn CO, Jurecic R, Levy RB. Development of a Concomitant Treg Expansion and Stem Cell Mobilization Protocol Which Enables Peripheral Blood Transplant Amelioration of Gvhd Following Pre-Clinical aHSCT Biology of Blood and Marrow Transplantation. 25: S292. DOI: 10.1016/J.Bbmt.2018.12.668 |
0.569 |
|
| 2019 |
Bader CS, Barreras H, Lightbourn CO, Copsel S, Meng J, Ahn J, Barber GN, Jin L, Roy S, Levy RB. The Innate Immune Sensor Sting Promotes CD8+ T Cell-Mediated Gvhd after Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 25: S49. DOI: 10.1016/J.Bbmt.2018.12.127 |
0.639 |
|
| 2019 |
Copsel S, Lightbourn CO, Barreras H, Lohse I, Wolf D, Bader CS, Manov J, Kale B, Shah D, Brothers S, Perez VL, Komanduri KV, Wahlestedt C, Levy RB. Identification of a BET Bromodomain Inhibitor That Enables Treg Function: A Combinatorial Strategy to Inhibit GVHD Biology of Blood and Marrow Transplantation. 25: S25-S26. DOI: 10.1016/J.Bbmt.2018.12.095 |
0.475 |
|
| 2018 |
Copsel SN, Lightbourn CO, Barreras H, Lohse I, Wolf D, Bader CS, Manov J, Kale BJ, Shah D, Brothers SP, Perez VL, Komanduri KV, Wahlestedt C, Levy RB. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT. Frontiers in Immunology. 9: 3104. PMID 30733722 DOI: 10.3389/fimmu.2018.03104 |
0.464 |
|
| 2018 |
Wolf D, Bader CS, Barreras H, Copsel S, Pfeiffer BJ, Lightbourn CO, Altman NH, Komanduri KV, Levy RB. Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models. Jci Insight. 3. PMID 30333311 DOI: 10.1172/jci.insight.121717 |
0.539 |
|
| 2018 |
Copsel S, Wolf D, Kale B, Barreras H, Lightbourn CO, Bader CS, Alperstein W, Altman NH, Komanduri KV, Levy RB. Very Low Numbers of CD4FoxP3 Tregs Expanded in Donors via TL1A-Ig and Low Dose IL-2 Exhibit a Distinct Activation / Functional Profile and Suppress GVHD in a Pre-Clinical Model. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29751114 DOI: 10.1016/j.bbmt.2018.04.026 |
0.47 |
|
| 2018 |
Bader CS, Barreras H, Lightbourn CO, Copsel S, Ahn J, Barber GN, Levy RB. The Innate Immune Sensor Sting Can Augment or Ameliorate Graft-Versus-Host Disease Dependent on the Genetic Disparity between Donors and Recipients Biology of Blood and Marrow Transplantation. 24: S176-S177. DOI: 10.1182/Blood.V130.Suppl_1.71.71 |
0.612 |
|
| 2018 |
Bader CS, Barreras H, Lightbourn CO, Copsel S, Ahn J, Barber GN, Jin L, Levy RB. The Innate Immune Sensor Sting Regulates Intestinal Inflammation and GVHD after Allogeneic Hematopoietic Stem Cell Transplantation in Knock-out and Human Allele Knock-in Recipient Mice Blood. 132: 65-65. DOI: 10.1182/Blood-2018-99-109999 |
0.552 |
|
| 2018 |
Copsel S, Wolf D, Kale B, Barreras H, Lightbourn CO, Bader CS, Alperstein W, Komanduri KV, Levy RB. Extremely Low Numbers of Donor Expanded Regulatory T Cells Characterized by Expression of an Activated Phenotype Can Suppress Graft-Versus-Host Disease Biology of Blood and Marrow Transplantation. 24: S170. DOI: 10.1016/j.bbmt.2017.12.118 |
0.46 |
|
| 2017 |
Wolf D, Barreras H, Bader CS, Copsel S, Lightbourn CO, Pfeiffer BJ, Altman NH, Podack ER, Komanduri KV, Levy RB. Marked in vivo Donor Treg Expansion via IL-2 and TL1A-Ig Stimulation Ameliorates GVHD but Preserves GVL in Recipients Post-HSCT. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28219835 DOI: 10.1016/J.Bbmt.2017.02.013 |
0.533 |
|
| 2017 |
Wolf D, Barreras H, Bader C, Copsel S, Lightbourn C, Pfeiffer B, Podack E, Komanduri K, Levy R. Marked in vivo Donor Treg expansion via targeting of the IL-2/CD25 and TL1A/TNFRSF25 pathways ameliorates GVHD and preserves GVL Cytotherapy. 19: S11-S12. DOI: 10.1016/J.Jcyt.2017.02.017 |
0.312 |
|
| 2016 |
Perez VL, Barsam A, Duffort S, Urbieta M, Barreras H, Lightbourn C, Levy RB. Novel Scoring Criteria for the Evaluation of Ocular Graft Versus Host Disease in a Pre-Clinical Allo-HSCT Animal Model. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 27492793 DOI: 10.1016/j.bbmt.2016.07.012 |
0.34 |
|
| 2016 |
Wolf D, Barreras H, Bader CS, Razdan S, Lightbourn CO, Pfeiffer BJ, Elliot SJ, Podack ER, Komanduri KV, Levy RB. Marked In Vivo Expansion of Donor T Regulatory Cells Via Targeting of the IL-2/CD25 and TL1A/TNFRSF25 Pathways Elicits Gender Differences and Ameliorates Gvhd Biology of Blood and Marrow Transplantation. 22: S418. DOI: 10.1016/J.Bbmt.2015.11.956 |
0.434 |
|
| 2015 |
Herretes S, Ross DB, Duffort S, Barreras H, Yaohong T, Saeed AM, Murillo JC, Komanduri KV, Levy RB, Perez VL. Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants. Investigative Ophthalmology & Visual Science. 56: 2348-57. PMID 25655798 DOI: 10.1167/Iovs.14-15630 |
0.815 |
|
| 2015 |
Wolf D, Barreras H, Bader CS, Lightbourn CO, Pfeiffer BJ, Podack ER, Komanduri KV, Levy RB. Targeting the IL-2/CD25 and TL1A/TNFRSF25 Pathways: A New Approach to Markedly Expand Donor Tregs in Multiple Compartments Leads to in Situ Immune Regulation Blood. 126: 4281-4281. DOI: 10.1182/Blood.V126.23.4281.4281 |
0.484 |
|
| 2015 |
Russell KB, Theall BP, Hernandez L, Wavering HM, Jurecic V, Andreansky S, Levy RB, Jurecic R. Novel Multi-Target Immunosuppressive Approach for Treatment of Severe Aplastic Anemia Blood. 126: 3611-3611. DOI: 10.1182/Blood.V126.23.3611.3611 |
0.482 |
|
| 2015 |
Wolf D, Barreras H, Komanduri KV, Podack ER, Levy RB. In Situ Manipulation of Tregs Via Combined IL-2 and TNFRSF25 Signaling Pre- and Post-Transplant: A Novel Approach to Regulate GVHD By Marked Expansion of CD4+Foxp3+ T Cells Biology of Blood and Marrow Transplantation. 21: S320. DOI: 10.1016/J.Bbmt.2014.11.689 |
0.486 |
|
| 2014 |
Ganguly S, Ross DB, Panoskaltsis-Mortari A, Kanakry CG, Blazar BR, Levy RB, Luznik L. Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice. Blood. 124: 2131-41. PMID 25139358 DOI: 10.1182/Blood-2013-10-525873 |
0.835 |
|
| 2014 |
Newman RG, Dee MJ, Malek TR, Podack ER, Levy RB. Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice. Blood. 123: 3045-55. PMID 24687086 DOI: 10.1182/Blood-2013-08-520775 |
0.418 |
|
| 2013 |
Su GC, Greanya ED, Partovi N, Yoshida EM, Shapiro RJ, Levy RD. Assessing medication adherence in solid-organ transplant recipients. Experimental and Clinical Transplantation : Official Journal of the Middle East Society For Organ Transplantation. 11: 475-81. PMID 24344939 DOI: 10.6002/ect.2013.0060 |
0.326 |
|
| 2013 |
Newman RG, Ross DB, Barreras H, Herretes S, Podack ER, Komanduri KV, Perez VL, Levy RB. The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success. Immunologic Research. 57: 125-39. PMID 24272856 DOI: 10.1007/S12026-013-8450-7 |
0.805 |
|
| 2013 |
Komanduri KV, Wieder ED, Benjamin CL, Levy RB. The evolving art of hematopoietic stem cell transplantation: translational research in post-transplant immune reconstitution and immunosuppression. Immunologic Research. 57: 140-50. PMID 24242818 DOI: 10.1007/s12026-013-8461-4 |
0.504 |
|
| 2013 |
Ross D, Jones M, Komanduri K, Levy RB. Antigen and lymphopenia-driven donor T cells are differentially diminished by post-transplantation administration of cyclophosphamide after hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1430-8. PMID 23819914 DOI: 10.1016/J.Bbmt.2013.06.019 |
0.841 |
|
| 2013 |
Tan Y, Abdulreda MH, Cruz-Guilloty F, Cutrufello N, Shishido A, Martinez RE, Duffort S, Xia X, Echegaray-Mendez J, Levy RB, Berggren PO, Perez VL. Role of T cell recruitment and chemokine-regulated intra-graft T cell motility patterns in corneal allograft rejection. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 13: 1461-73. PMID 23679575 DOI: 10.1111/Ajt.12228 |
0.536 |
|
| 2013 |
Shindo T, Kim TK, Benjamin CL, Wieder ED, Levy RB, Komanduri KV. MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner. Blood. 121: 4617-26. PMID 23575444 DOI: 10.1182/blood-2012-12-476218 |
0.496 |
|
| 2013 |
Martin PJ, Levy RB. Immune Rejection: The Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation (from Mice to Humans) Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation. 83-122. DOI: 10.1016/B978-0-12-416004-0.00005-7 |
0.397 |
|
| 2011 |
Levy RB. Repertoire isn't everything for GVHD. Blood. 118: 5985-7. PMID 22134908 DOI: 10.1182/blood-2011-08-370387 |
0.347 |
|
| 2011 |
Quon BS, Reid JD, Wong P, Wilcox PG, Javer A, Wilson JM, Levy RD. Burkholderia gladioli - a predictor of poor outcome in cystic fibrosis patients who receive lung transplants? A case of locally invasive rhinosinusitis and persistent bacteremia in a 36-year-old lung transplant recipient with cystic fibrosis. Canadian Respiratory Journal : Journal of the Canadian Thoracic Society. 18: e64-5. PMID 22059186 DOI: 10.1155/2011/304179 |
0.337 |
|
| 2011 |
Bayer AL, Chirinos J, Cabello C, Yang J, Matsutani T, Malek TR, Levy RB. Expansion of a restricted residual host T reg-cell repertoire is dependent on IL-2 following experimental autologous hematopoietic stem transplantation. European Journal of Immunology. 41: 3467-78. PMID 21928285 DOI: 10.1002/Eji.201141611 |
0.538 |
|
| 2011 |
Newman RG, Podack ER, Levy RB. Combining Early Heat Shock Protein Vaccination with Directed IL-2 Leads to Effective Anti-Tumor Immunity in Autologous Hematopoietic Cell Transplantation Recipients Blood. 118: 998-998. DOI: 10.1182/Blood.V118.21.998.998 |
0.432 |
|
| 2011 |
Ross DB, Komanduri KV, Levy RB. Post-Transplant Cyclophosphamide (PTC) Gvhd Prophylaxis: Kinetics of Proliferation of Donor T Cells Affects Susceptibility to PTC Administration, Blood. 118: 4029-4029. DOI: 10.1182/Blood.V118.21.4029.4029 |
0.848 |
|
| 2011 |
Shindo T, Kim TK, Benjamin CL, Levy RB, Wieder ED, Komanduri KV. MEK Inhibitors Selectively Suppress Human T Cell Alloreactivity in a Memory Stage-Dependent Manner, Blood. 118: 4014-4014. DOI: 10.1182/blood.v118.21.4014.4014 |
0.458 |
|
| 2011 |
Zhang Y, Tadmor T, Eliav Y, Schreiber TH, Podack ER, Levy R, Shin S, Rosenblatt JD. Abstract LB-164: B lymphocytes inhibit anti-tumor response in a murine EMT6 tumor model by facilitating expansion of T regulatory cells Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-164 |
0.44 |
|
| 2010 |
Schreiber TH, Wolf D, Tsai MS, Chirinos J, Deyev VV, Gonzalez L, Malek TR, Levy RB, Podack ER. Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation. The Journal of Clinical Investigation. 120: 3629-40. PMID 20890040 DOI: 10.1172/Jci42933 |
0.359 |
|
| 2010 |
Tawara I, Shlomchik WD, Jones A, Zou W, Nieves E, Liu C, Toubai T, Duran-Struuck R, Sun Y, Clouthier SG, Evers R, Lowler KP, Levy RB, Reddy P. A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 185: 3866-72. PMID 20810991 DOI: 10.4049/Jimmunol.1001625 |
0.585 |
|
| 2010 |
Urbieta M, Barao I, Jones M, Jurecic R, Panoskaltsis-Mortari A, Blazar BR, Murphy WJ, Levy RB. Hematopoietic progenitor cell regulation by CD4+CD25+ T cells. Blood. 115: 4934-43. PMID 20200356 DOI: 10.1182/Blood-2009-04-218826 |
0.553 |
|
| 2010 |
Adeegbe D, Levy RB, Malek TR. Allogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance. Blood. 115: 1932-40. PMID 20040758 DOI: 10.1182/Blood-2009-08-238584 |
0.515 |
|
| 2010 |
Newman RG, Podack ER, Levy RB. CD8 T Cell Expansion Early Post-Autologous HSCT Following Vaccination with Lymphoma Cells Secreting gp96-Ig and Augmentation by IL-2 Antibody Cytokine Complex Blood. 116: 4286-4286. DOI: 10.1182/Blood.V116.21.4286.4286 |
0.399 |
|
| 2010 |
Jones M, Ross DB, Komanduri KV, Levy RB. Post-Transplant Cyclophosphamide Treatment Ameliorates Experimental Gvhd While Permitting Lymphopenic Expansion of Non-Host Reactive Donor T Cells. Blood. 116: 3751-3751. DOI: 10.1182/Blood.V116.21.3751.3751 |
0.846 |
|
| 2009 |
Shatry A, Chirinos J, Gorin MA, Jones M, Levy RB. Targeting Treg cells in situ: emerging expansion strategies for (CD4(+)CD25(+)) regulatory T cells. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 1239-43. PMID 19747630 DOI: 10.1016/j.bbmt.2009.06.009 |
0.466 |
|
| 2009 |
Shatry A, Levy RB. In situ activation and expansion of host tregs: a new approach to enhance donor chimerism and stable engraftment in major histocompatibility complex-matched allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 785-94. PMID 19539209 DOI: 10.1016/j.bbmt.2009.03.011 |
0.599 |
|
| 2009 |
Kutlesa S, Zayas J, Valle A, Levy RB, Jurecic R. T-cell differentiation of multipotent hematopoietic cell line EML in the OP9-DL1 coculture system. Experimental Hematology. 37: 909-23. PMID 19447159 DOI: 10.1016/J.Exphem.2009.05.002 |
0.411 |
|
| 2009 |
Bayer AL, Jones M, Chirinos J, de Armas L, Schreiber TH, Malek TR, Levy RB. Host CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT. Blood. 113: 733-43. PMID 18832651 DOI: 10.1182/Blood-2008-08-173179 |
0.643 |
|
| 2009 |
Shatry A, Gorin MA, Chirinos JG, Levy RB. Facilitating Engraftment After MHC-Matched, Allogeneic BMT by IL-2 / Anti IL-2 Complex Treatment Requires Targeting CD25 On, and Activation in Situ of, Residual CD4 Tregs. Blood. 114: 66-66. DOI: 10.1182/blood.v114.22.66.66 |
0.52 |
|
| 2009 |
Jones M, Shatry A, Blazar BR, Levy RB. IL-2 + Anti-IL2 Complex in Situ Stimulation of Host Tregs Combined with Absence of Donor B7.1 / B7.2: A Novel Approach to Facilitate Chimerism in RIC MHC-Matched Miha-Mismatched BMT Recipients. Blood. 114: 2441-2441. DOI: 10.1182/Blood.V114.22.2441.2441 |
0.558 |
|
| 2009 |
Urbieta M, Levy R. CD4+Foxp3+ Regulatory T Cells Mediate Suppression of Colony Forming Activity of Leukemic as Well as Primary Myeloid Progenitors Biology of Blood and Marrow Transplantation. 15: 48. DOI: 10.1016/j.bbmt.2008.12.147 |
0.439 |
|
| 2009 |
Shatry A, Levy R. In Situ Activation of Host CD4+ CD25+ FoxP3+ T Cells: A New Strategy for Circumventing Resistance and Establishment of Hematopoietic Engraftment After MHC-Matched Allogeneic HCT Biology of Blood and Marrow Transplantation. 15: 10. DOI: 10.1016/j.bbmt.2008.12.027 |
0.435 |
|
| 2008 |
Taylor PA, Ehrhardt MJ, Lees CJ, Panoskaltsis-Mortari A, Krieg AM, Sharpe AH, Murphy WJ, Serody JS, Hemmi H, Akira S, Levy RB, Blazar BR. TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection. Blood. 112: 3508-16. PMID 18614760 DOI: 10.1182/Blood-2007-09-113670 |
0.432 |
|
| 2008 |
Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients. Therapeutic Drug Monitoring. 30: 282-91. PMID 18520599 DOI: 10.1097/FTD.0b013e318166eba0 |
0.319 |
|
| 2008 |
Ting LS, Partovi N, Levy RD, Ignaszewski AP, Ensom MH. Performance of limited sampling strategies for predicting mycophenolic acid area under the curve in thoracic transplant recipients. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 27: 325-8. PMID 18342756 DOI: 10.1016/j.healun.2007.12.009 |
0.339 |
|
| 2008 |
Shatry A, Levy RB. Administration of IL-2-Anti-IL2mAb Complex Post-Allogeneic HCT: a New Approach to Facilitate Rapid and Stable Hematopoietic Chimerism Following Reduced Intensity Conditioning and Experimental HCT Blood. 112: 70-70. DOI: 10.1182/BLOOD.V112.11.70.70 |
0.576 |
|
| 2008 |
Chirinos JG, Adeegbe D, Jones M, Urbieta M, Malek TR, Levy RB. Cytolytically Defective Tregs Can Prevent Spontaneous Autoimmune Disease and Gvhd, but Fail to Suppress Autochthonous Lymphoproliferation Blood. 112: 3518-3518. DOI: 10.1182/Blood.V112.11.3518.3518 |
0.521 |
|
| 2008 |
Urbieta M, Barao I, Chirinos J, Panoskaltsis-Mortari A, Blazar B, Murphy W, Levy R. 121: Interaction of CD4+CD25+Foxp3+ Regulatory T Cells with Hematopoietic Progenitor Cells Reveals Two Distinct Pathways of Regulation Biology of Blood and Marrow Transplantation. 14: 46-47. DOI: 10.1016/J.Bbmt.2007.12.130 |
0.421 |
|
| 2008 |
Bayer A, Jones M, Urbieta M, Chirinos J, Schreiber T, Armas L, Thomas M, Levy R. 44: The CD4+CD25+Foxp3+ Compartment Following Conditioning and Transplant: Host Treg Cells Expand and Comprise the Predominant Component for Several Months During Reconstitution post-HCT Biology of Blood and Marrow Transplantation. 14: 18-19. DOI: 10.1016/j.bbmt.2007.12.052 |
0.464 |
|
| 2007 |
Keith MR, Levy RB. Transplant conditions determine the contribution of homeostatically expanded donor CD8 memory cells to host lymphoid reconstitution following syngeneic HCT. Experimental Hematology. 35: 1303-15. PMID 17553613 DOI: 10.1016/J.Exphem.2007.04.008 |
0.806 |
|
| 2007 |
Shatry AM, Roopenian DC, Levy RB. Survival and function of MiHA epitope-specific host CD8 TM cells following ablative conditioning and HCT. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 293-8. PMID 17317582 DOI: 10.1016/J.Bbmt.2006.12.440 |
0.523 |
|
| 2007 |
Bayer AL, Jones M, Urbieta M, Chirinos J, Schreiber T, De Armas L, Malek TR, Levy RB. Surviving Host CD4+CD25+Foxp3+ Cells Following Ablative Conditioning Expand and Comprise the Major Component of the Treg Compartment during the Lymphoid Reconstitution Period Following HCT. Blood. 110: 65-65. DOI: 10.1182/Blood.V110.11.65.65 |
0.623 |
|
| 2007 |
Urbieta M, Barao I, Panoskaltsis-Mortari A, Blazar BR, Murphy WJ, Levy RB. CD4+CD25+Foxp3+ Regulatory T Cell Function Outside the Immune System: Differential Regulation of Hematopoietic Progenitor Cell Populations. Blood. 110: 64-64. DOI: 10.1182/Blood.V110.11.64.64 |
0.379 |
|
| 2007 |
Shatry AM, Levy RB. Pre-Transplant Infusion of Donor CD4+ CD25+ T Cells Suppresses Host Anti-Donor MiHA-Specific CD8 T Cells and Facilitates Stable Mixed Chimerism Following MHC-Matched Allogeneic Marrow Transplant. Blood. 110: 3254-3254. DOI: 10.1182/blood.v110.11.3254.3254 |
0.636 |
|
| 2007 |
Shatry A, Levy R. 272: Demonstration of a single MiHA specificity recognized by memory CD8 T cells which induces resistance to MHC-matched hematopoietic allografts Biology of Blood and Marrow Transplantation. 13: 99. DOI: 10.1016/j.bbmt.2006.12.277 |
0.415 |
|
| 2007 |
Jones M, Blazar B, Zimmerman Z, Levy R. 250: Co-stimulatory molecule expression by transplanted donor APC and host CD4 T cells is required to elicit resistance against MHC-matched hematopoietic allografts following reduced intensity conditioning Biology of Blood and Marrow Transplantation. 13: 92. DOI: 10.1016/j.bbmt.2006.12.255 |
0.552 |
|
| 2007 |
Urbieta M, Barao I, Murphy W, Blazar B, Jones M, Levy R. 123: Regulation of hematopoietic colony forming cells by CD4+CD25+ T cells Biology of Blood and Marrow Transplantation. 13: 47. DOI: 10.1016/J.Bbmt.2006.12.127 |
0.431 |
|
| 2007 |
Roskos M, Levy R. 48: Transplant conditions determine the contribution of homeostatically expanded donor CD8 cells to host lymphoid reconstitution following hematopoietic cell transplantation Biology of Blood and Marrow Transplantation. 13: 20. DOI: 10.1016/j.bbmt.2006.12.051 |
0.574 |
|
| 2006 |
Zimmerman ZF, Levy RB. MiHA reactive CD4 and CD8 T-cells effect resistance to hematopoietic engraftment following reduced intensity conditioning. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 6: 2089-98. PMID 16796724 DOI: 10.1111/j.1600-6143.2006.01428.x |
0.555 |
|
| 2006 |
Adeegbe D, Bayer AL, Levy RB, Malek TR. Cutting edge: allogeneic CD4+CD25+Foxp3+ T regulatory cells suppress autoimmunity while establishing transplantation tolerance. Journal of Immunology (Baltimore, Md. : 1950). 176: 7149-53. PMID 16751356 DOI: 10.4049/Jimmunol.176.12.7149 |
0.575 |
|
| 2006 |
Barao I, Hanash AM, Hallett W, Welniak LA, Sun K, Redelman D, Blazar BR, Levy RB, Murphy WJ. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 5460-5. PMID 16567639 DOI: 10.1073/Pnas.0509249103 |
0.738 |
|
| 2006 |
Jones M, Blazar B, Zimmerman Z, Levy RB. Transplanted Donor APC Co-Stimulatory Molecule Expression Is Required To Elicit Host T Cell Resistance in MHC-Matched Allogeneic BMT Recipients Following Reduced Intensity Conditioning. Blood. 108: 620-620. DOI: 10.1182/blood.v108.11.620.620 |
0.604 |
|
| 2006 |
Shatry AM, Levy RB. Identification of a Single MiHA Specificity That Induces Resistance to MHC-Matched Allogeneic HCT. Blood. 108: 3216-3216. DOI: 10.1182/blood.v108.11.3216.3216 |
0.608 |
|
| 2006 |
Roskos M, Levy RB. Transplanted Donor CD8 TN Convert to TM in Severely Lymphopenic HCT Recipients and Are Distinguishable from Bona Fide Donor CD8 TM. Blood. 108: 3214-3214. DOI: 10.1182/blood.v108.11.3214.3214 |
0.559 |
|
| 2006 |
Urbieta M, Barao I, Jones M, Murphy WJ, Levy RB. Regulation of Hematopoietic Colony Forming Cells by CD4+CD25+ T Cells: A Role for T Regulatory Cells in Hematopoiesis?. Blood. 108: 3181-3181. DOI: 10.1182/blood.v108.11.3181.3181 |
0.468 |
|
| 2006 |
Roskos M, Levy RB. The Rapid Ex Vivo Generation of an Immunodominant Antigen-Specific Memory CD8 Population and Its Subsequent Homeostatic Expansion in Ablatively-Conditioned HCT Recipients. Blood. 108: 3172-3172. DOI: 10.1182/blood.v108.11.3172.3172 |
0.531 |
|
| 2006 |
Deyev V, Roskos M, Levy RB, Podack ER. TNFR25 Expression on CD4+CD25+ T Cells: Down Modulation of Regulatory Activity. Blood. 108: 3165-3165. DOI: 10.1182/Blood.V108.11.3165.3165 |
0.452 |
|
| 2006 |
Roskos M, Levy R. Transplant conditions determine the kinetics and frequency of homeostatically expanding memory CD8 T cells in syngeneic HCT recipients Biology of Blood and Marrow Transplantation. 12: 83. DOI: 10.1016/j.bbmt.2005.11.258 |
0.508 |
|
| 2006 |
Shatry A, Levy R. Anti-minor histocompatibility antigen specific CD8 memory cells respond differently to antigen and antigen-independent activation in the spleen and marrow compartments following HCT Biology of Blood and Marrow Transplantation. 12: 79. DOI: 10.1016/j.bbmt.2005.11.247 |
0.312 |
|
| 2006 |
Hanash A, Jones A, Levy R. The role of MHC class II in CD4+CD25+ T cell-mediated facilitation of allogeneic hematopoietic engraftment and suppression of GVHD Biology of Blood and Marrow Transplantation. 12: 58. DOI: 10.1016/J.Bbmt.2005.11.181 |
0.691 |
|
| 2005 |
Greanya ED, Partovi N, Yoshida EM, Shapiro RJ, Levy RD, Sherlock CH, Stephens GM. The role of the cytomegalovirus antigenemia assay in the detection and prevention of cytomegalovirus syndrome and disease in solid organ transplant recipients: A review of the British Columbia experience. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie MéDicale / Ammi Canada. 16: 335-41. PMID 18159516 DOI: 10.1155/2005/679386 |
0.301 |
|
| 2005 |
Zimmerman Z, Jones M, Shatry A, Komatsu M, Mammolenti M, Levy R. Cytolytic Pathways Used by Effector Cells Derived from Recipient Naive and Memory T Cells and Natural Killer Cells in Resistance to Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation. 11: 957-971. PMID 16338617 DOI: 10.1016/J.Bbmt.2005.07.006 |
0.624 |
|
| 2005 |
Zimmerman Z, Shatry A, Deyev V, Podack E, Mammolenti M, Blazar BR, Yagita H, Levy RB. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 11: 576-86. PMID 16041307 DOI: 10.1016/J.Bbmt.2005.05.006 |
0.573 |
|
| 2005 |
Hanash AM, Levy RB. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood. 105: 1828-36. PMID 15494429 DOI: 10.1182/Blood-2004-08-3213 |
0.804 |
|
| 2005 |
Maeda Y, Levy RB, Reddy P, Liu C, Clouthier SG, Teshima T, Ferrara JL. Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease. Blood. 105: 2023-7. PMID 15466930 DOI: 10.1182/blood-2004-08-3036 |
0.586 |
|
| 2005 |
Levy RB. GVHD: Complication and challenge to successful allogeneic hematopoietic cell transplantation Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents. 5: 585-597. DOI: 10.2174/156801305774962231 |
0.536 |
|
| 2005 |
Shatry AM, Levy RB. Contrasting Effects of Post-Transplant Lymphopenia on Proliferation and Degranulation in Antigen-Specific CD8 Memory T Cells. Blood. 106: 66-66. DOI: 10.1182/blood.v106.11.66.66 |
0.564 |
|
| 2005 |
Zimmerman ZF, Jones MV, Stohlman SA, Levy RB. Memory Effector Cells but Not Effector Cells Derived from Naive T Cells Can Utilize a Non-Perforin and Non-FasL Pathway To Inhibit Allogeneic Progenitor Cell Function Ex-Vivo. Blood. 106: 3029-3029. DOI: 10.1182/Blood.V106.11.3029.3029 |
0.377 |
|
| 2005 |
Zhang YD, Nechushtan H, Jones M, Chan A, Shin S, Pham D, Cho H, Yi K, Levy R, Rosenblatt JD. Rituximab Mediated Depletion of B Cells Following Transplant of Human CD20 Transgenic Mouse Bone Marrow Results in Prolonged B Cell Depletion and Augmented Anti-Tumor Immune Response. Blood. 106: 2205-2205. DOI: 10.1182/Blood.V106.11.2205.2205 |
0.569 |
|
| 2005 |
Murphy WJ, Bareo I, Hanash AM, Welniak LA, Sun K, Blazar BR, Levy RB. Suppression of NK Cell-Mediated Bone Marrow Cell Rejection by CD4+CD25+ Regulatory T Cells: Linkage of Adaptive to Innate Responses. Blood. 106: 2195-2195. DOI: 10.1182/Blood.V106.11.2195.2195 |
0.746 |
|
| 2005 |
Levy RB, Jones A. CD4+CD25+ T Cells Can Inhibit CD8 T Cell Mediated GVHD: Requirement for In Vivo Recognition of Allogeneic Host MHC Class II Antigens. Blood. 106: 1307-1307. DOI: 10.1182/blood.v106.11.1307.1307 |
0.579 |
|
| 2005 |
Roskos M, Levy RB. Higher Homeostatic Set-Point for Transplanted Naive vs. Memory CD8 T Cells during Immune Reconstitution Following Ablative Conditioning and HCT. Blood. 106: 1264-1264. DOI: 10.1182/blood.v106.11.1264.1264 |
0.56 |
|
| 2005 |
Zimmerman Z, Levy R. Major cytotoxic pathways are required for effective resistance against hematopoietic allografts by effector cells derived from naıve but not memory recipient T cells Biology of Blood and Marrow Transplantation. 11: 56. DOI: 10.1016/j.bbmt.2004.12.168 |
0.439 |
|
| 2005 |
Roskos M, Levy R. CTL activity of in vitro-derived memory T cells is more efficient than naıve T cells in syngeneic recipients immediately following experimental BMT Biology of Blood and Marrow Transplantation. 11: 54. DOI: 10.1016/j.bbmt.2004.12.162 |
0.42 |
|
| 2005 |
Zimmerman Z, Levy R. Absence of CD80/86 expression on donor bone marrow is sufficient to circumvent T cell mediated resistance following experimental “mini” MHC-matched allogeneic BMT Biology of Blood and Marrow Transplantation. 11: 30-31. DOI: 10.1016/j.bbmt.2004.12.087 |
0.451 |
|
| 2005 |
Hanash A, Levy R. The requirement of MHC class II for donor CD4+CD25+ T cell-mediated support of early allogeneic progenitor cell engraftment Biology of Blood and Marrow Transplantation. 11: 30. DOI: 10.1016/J.Bbmt.2004.12.086 |
0.716 |
|
| 2005 |
Shatry A, Levy R. Identification and tissue distribution of antigen-specific recipient anti-donor CD8+ T cells that resist hematopietic engraftment following MHC-matched allogeneic progenitor cell transplants Biology of Blood and Marrow Transplantation. 11: 7-8. DOI: 10.1016/j.bbmt.2004.12.021 |
0.587 |
|
| 2004 |
Mammolenti M, Gajavelli S, Tsoulfas P, Levy R. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro. Stem Cells (Dayton, Ohio). 22: 1101-10. PMID 15536199 DOI: 10.1634/Stemcells.22-6-1101 |
0.555 |
|
| 2004 |
Shatry AM, Levy RB. Engraftment of splenic tissue as a method to investigate repopulation by hematopoietic cells from host and donor marrow. Stem Cells and Development. 13: 390-9. PMID 15345133 DOI: 10.1089/SCD.2004.13.390 |
0.475 |
|
| 2004 |
Blazar BR, Levy RB, Mak TW, Panoskaltsis-Mortari A, Muta H, Jones M, Roskos M, Serody JS, Yagita H, Podack ER, Taylor PA. CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 173: 2933-41. PMID 15322151 DOI: 10.4049/Jimmunol.173.5.2933 |
0.39 |
|
| 2004 |
Adkins B, Jones M, Bu Y, Levy RB. Neonatal tolerance revisited again: specific CTL priming in mouse neonates exposed to small numbers of semi- or fully allogeneic spleen cells. European Journal of Immunology. 34: 1901-9. PMID 15214038 DOI: 10.1002/eji.200324271 |
0.382 |
|
| 2004 |
Marks L, Altman NH, Podack ER, Levy RB. Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients. Transplantation. 77: 804-12. PMID 15077018 DOI: 10.1097/01.Tp.0000110416.96307.D5 |
0.842 |
|
| 2004 |
Shatry AM, Jones M, Levy RB. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants. Stem Cells and Development. 13: 51-62. PMID 15068693 DOI: 10.1089/154732804773099254 |
0.457 |
|
| 2004 |
Warburton DE, Sheel AW, Hodges AN, Stewart IB, Yoshida EM, Levy RD, McKenzie DC. Effects of upper extremity exercise training on peak aerobic and anaerobic fitness in patients after transplantation. The American Journal of Cardiology. 93: 939-43. PMID 15050506 DOI: 10.1016/J.AMJCARD.2003.12.030 |
0.328 |
|
| 2004 |
Marks L, Levy RB. The cytotoxic potential of regulatory T cells: what has been learned from gene knockout model systems? Transplantation. 77: S19-22. PMID 14726764 DOI: 10.1097/01.Tp.0000106473.46037.83 |
0.797 |
|
| 2004 |
Hanash A, Levy RB. Donor CD4+CD25+ T Cells Require Syngeneic MHC Class II for Initial Support of MHC-Mismatched Hematopoietic Engraftment. Blood. 104: 251-251. DOI: 10.1182/Blood.V104.11.251.251 |
0.754 |
|
| 2004 |
Shatry AM, Levy RB. Minor Histocompatibility Antigen-Specific CD8+ Memory T Cells in Hematopoietic Compartments Survive the Immediate Non-Ablative and Ablative TBI Milieu. Blood. 104: 2142-2142. DOI: 10.1182/blood.v104.11.2142.2142 |
0.486 |
|
| 2004 |
Zimmerman ZF, Levy RB. Donor Antigen Presenting Cell CD80/86 Function Is Required for Eliciting T Cell Resistance Against Progenitor Cell Engraftment in an MHC Matched Allogeneic Non-Myeloablative Transplantation Model. Blood. 104: 2137-2137. DOI: 10.1182/blood.v104.11.2137.2137 |
0.576 |
|
| 2004 |
Zimmerman ZF, Levy RB. Both Recipient TNaive and TMemory Cells Mediate Efficient Resistance Against Marrow Allografts in the Absence of Major Cytotoxic Effector Pathways. Blood. 104: 2130-2130. DOI: 10.1182/blood.v104.11.2130.2130 |
0.554 |
|
| 2004 |
Jones M, Jones A, Levy R. Adoptive transfer of primed T cells prior to ablative conditioning and BMT results in syngeneic anti-tumor immunity early post-transplant Biology of Blood and Marrow Transplantation. 10: 51. DOI: 10.1016/j.bbmt.2003.12.254 |
0.478 |
|
| 2004 |
Zimmerman Z, Jones A, Deyev V, Blazar B, Yagita H, Podack E, Levy R. Perforin, FasL, TNFR1, TWEAK, TRAIL, and DR3-TL1a are not required for efficient T cell mediated resistance against allogeneic bone marrow grafts Biology of Blood and Marrow Transplantation. 10: 39. DOI: 10.1016/J.Bbmt.2003.12.183 |
0.373 |
|
| 2004 |
Shatry A, Van der Put E, Riley R, Jones M, Levy R. A requirement for the spleen in preventing sustained imbalance of B220+ cells and GR-1+ cells during reconstitution following syngeneic and allogeneic BMT Biology of Blood and Marrow Transplantation. 10: 67. DOI: 10.1016/J.Bbmt.2003.12.060 |
0.676 |
|
| 2004 |
Hanash A, Levy R. Dissection of an MHC mismatched allogeneic transplant model during donor CD4+CD25+ T-cell facilitation of hematopoietic progenitors Biology of Blood and Marrow Transplantation. 10: 10-11. DOI: 10.1016/J.Bbmt.2003.12.030 |
0.755 |
|
| 2003 |
Ensom MH, Partovi N, Decarie D, Ignaszewski AP, Fradet GJ, Levy RD. Mycophenolate pharmacokinetics in early period following lung or heart transplantation. The Annals of Pharmacotherapy. 37: 1761-7. PMID 14632536 DOI: 10.1345/aph.1D099 |
0.359 |
|
| 2003 |
Cook RC, Fradet G, Müller NL, Worsely DF, Ostrow D, Levy RD. Noninvasive investigations for the early detection of chronic airways dysfunction following lung transplantation Canadian Respiratory Journal. 10: 76-83. PMID 12687027 DOI: 10.1155/2003/848717 |
0.31 |
|
| 2003 |
Komatsu M, Mammolenti M, Jones M, Jurecic R, Sayers TJ, Levy RB. Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing. Blood. 101: 3991-9. PMID 12521999 DOI: 10.1182/Blood-2002-09-2859 |
0.613 |
|
| 2003 |
Zimmerman Z, Baez J, Roskos M, Mammolenti M, Levy R. 113Analysis of CD4+CD25+ T regulatory cell survival and function following in vitro and in vivo irradiation Biology of Blood and Marrow Transplantation. 9: 99. DOI: 10.1016/S1083-8791(03)80114-3 |
0.397 |
|
| 2003 |
Hanash A, Levy R. 106Donor CD8 T-cell support of hematopoietic progenitor activity during syngeneic BMT Biology of Blood and Marrow Transplantation. 9: 96-97. DOI: 10.1016/S1083-8791(03)80107-6 |
0.542 |
|
| 2003 |
Hanash A, Mammolenti M, Levy R. 54 Donor CD4+CD25+ regulatory T-cells, A CD4+ population capable of supporting hematopoietic engraftment without inducing GVHD Biology of Blood and Marrow Transplantation. 9: 81. DOI: 10.1016/S1083-8791(03)80055-1 |
0.42 |
|
| 2002 |
Jiang Z, Adams GB, Hanash AM, Scadden DT, Levy RB. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 8: 588-96. PMID 12463477 DOI: 10.1053/Bbmt.2002.V8.Abbmt080588 |
0.783 |
|
| 2001 |
Jiang Z, Podack E, Levy RB. Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesis. Blood. 98: 390-7. PMID 11435308 DOI: 10.1182/Blood.V98.2.390 |
0.589 |
|
| 2000 |
Jones M, Komatsu M, Levy RB. Cytotoxically impaired transplant recipients can efficiently resist major histocompatibility complex--matched bone marrow allografts. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 6: 456-64. PMID 10975515 DOI: 10.1016/S1083-8791(00)70038-3 |
0.536 |
|
| 1999 |
Marks L, Levy RB. SYNGENEIC LYMPHOCYTE INFUSION (SLI) FOLLOWING ALLOGENEIC BMT RESULTS IN A DELAY OF CLINICAL GVHD AND PROLONGED RECIPIENT SURVIVAL: A MODEL FOR GVHD RESCUE. Transplantation. 67: S175. DOI: 10.1097/00007890-199904150-00701 |
0.781 |
|
| 1998 |
Bennett M, Taylor PA, Austin M, Baker MB, Schook LB, Rutherford M, Kumar V, Podack ER, Mohler KM, Levy RB, Blazar BR. Cytokine and cytotoxic pathways of NK cell rejection of class I-deficient bone marrow grafts: influence of mouse colony environment. International Immunology. 10: 785-90. PMID 9678759 DOI: 10.1093/Intimm/10.6.785 |
0.355 |
|
| 1997 |
Baker MB, Riley RL, Podack ER, Levy RB. Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function. Proceedings of the National Academy of Sciences of the United States of America. 94: 1366-71. PMID 9037059 DOI: 10.1073/Pnas.94.4.1366 |
0.788 |
|
| 1996 |
Alard P, Levy R, Kosiewicz M, Jones M, Streilein J. MHC class II tolerant T cells undergo apoptosis upon re-exposure to tolerogen in vivo Transplant Immunology. 4: 76-80. PMID 8762018 DOI: 10.1016/S0966-3274(96)80042-6 |
0.517 |
|
| 1996 |
Baker MB, Altman NH, Podack ER, Levy RB. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. The Journal of Experimental Medicine. 183: 2645-56. PMID 8676085 DOI: 10.1084/Jem.183.6.2645 |
0.56 |
|
| 1996 |
Jones M, Cray C, Levy RB. Concurrent MCMV infection augments donor antihost-specific activity and alters clinical outcome following experimental allogenic bone marrow transplantation. Transplantation. 61: 856-61. PMID 8623149 DOI: 10.1097/00007890-199603270-00002 |
0.559 |
|
| 1995 |
Levy RB, Baker M, Podack ER. Perforin-deficient T cells can induce acute graft-versus-host disease after transplantation of MHC-matched or MHC disparate allogeneic bone marrow. Annals of the New York Academy of Sciences. 770: 366-7. PMID 8597376 DOI: 10.1111/J.1749-6632.1995.Tb31070.X |
0.495 |
|
| 1993 |
Cray C, Levy RB. CD8+ and CD4+ T Cells Contribute to the Exacerbation of Class I MHC Disparate Graft-vs-Host Reaction by Concurrent Murine Cytomegalovirus Infection Clinical Immunology and Immunopathology. 67: 84-90. PMID 8095196 DOI: 10.1006/clin.1993.1048 |
0.489 |
|
| 1993 |
Levy RB, Streilein JW. Approaches to the Study of T-Lymphocytes in Transplantation Tolerance Immunomethods. 2: 125-135. DOI: 10.1006/immu.1993.1015 |
0.489 |
|
| 1990 |
Richardson JC, Levy RB. The use of primed cytotoxic T lymphocytes as a highly sensitive and accurate method for the detection of MHC disparate allogeneic cells. Journal of Immunological Methods. 127: 79-90. PMID 2319143 DOI: 10.1016/0022-1759(90)90343-T |
0.378 |
|
| 1990 |
Cray C, Levy RB. The presence of infectious virus but not conventional antigen can exacerbate graft-versus-host reactions. Scandinavian Journal of Immunology. 32: 177-82. PMID 1975119 DOI: 10.1111/j.1365-3083.1990.tb02907.x |
0.406 |
|
| 1988 |
Richardson JC, Levy RB. Utilization of antigen specific cytotoxic T-cells as a sensitive approach to investigate the fate of placentally injected allogeneic lymphocytes. Journal of Reproductive Immunology. 11: 245-59. PMID 3500308 DOI: 10.1016/0165-0378(87)90062-3 |
0.43 |
|
| 1983 |
Hurtenbach U, Shearer GM, Levy RB. Cross-reactive recognition of alloantigens and certain B6 mutant antigens by antigen-specific and polyclonally activated cytotoxic effector cells. Cellular Immunology. 80: 163-71. PMID 6191874 DOI: 10.1016/0008-8749(83)90103-X |
0.326 |
|
| 1982 |
Fujiwara H, Levy RB, Shearer GM. Studies on in-vivo priming of the trinitrophenyl-reactive cytotoxic effector-system. III. Are helper T cells involved in the in-vitro generation of cross-reactive as well as restricted cytotoxic responses? Immunobiology. 160: 472-8. PMID 6978282 DOI: 10.1016/S0171-2985(82)80009-0 |
0.347 |
|
| 1981 |
Tamaki K, Fujiwara H, Levy RB, Shearer GM, Katz SI. Hapten specific TNP-reactive cytotoxic effector cells using epidermal cells as targets. The Journal of Investigative Dermatology. 77: 225-9. PMID 7276618 DOI: 10.1111/1523-1747.ep12480043 |
0.312 |
|
| Show low-probability matches. |